Jagsonpal Pharmaceuticals Buyback 2026 vs Wipro Buyback 2026

Comparison between Jagsonpal Pharmaceuticals Buyback 2026 and Wipro Buyback 2026.

Buyback Details

Jagsonpal Pharmaceuticals Buyback 2026 is a Tender Offer buyback proposed to list at NSE, BSE while Wipro Buyback 2026 is a Tender Offer proposed to list at BSE, NSE.

 Jagsonpal Pharmaceuticals Ltd.Wipro Ltd.
LogoJagsonpal Pharmaceuticals Buyback 2026 LogoWipro Buyback 2026 Logo
Type of BuybackTender OfferTender Offer
Listing AtNSE, BSEBSE, NSE
Face Value₹10 per share₹2 per share
Buyback Price₹250 per share₹250 per share
Issue Size16,00,000 shares60,00,00,000 shares
Issue Size (Amount)₹40.00 Crores₹15,000.00 Crores
Buyback Ratio
CategoryEntitlement RatioShares Offered
Small Shareholders47 : 6372,40,975
General Category47 : 63713,59,025

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

CategoryEntitlement RatioShares Offered
Small Shareholders11 : 569,00,00,000
General Category10 : 19751,00,00,000

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

RegistrarMCS Share Transfer Agent Ltd.Kfin Technologies Ltd.
Lead ManagersCentrum Capital Ltd.JM Financial Ltd.
Necessity of the buyback

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Improve financial ratios such as earnings per share and return on equity.

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Optimise the Company’s capital structure.
  • Improve financial ratios such as earnings per share and return on equity.
  • Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

Buyback Timetable

Jagsonpal Pharmaceuticals Buyback 2026 and Wipro Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Jagsonpal Pharmaceuticals Buyback 2026 Buyback record date is May 04, 2026. Wipro Buyback 2026 Buyback record date is Jun 05, 2026.

 Jagsonpal Pharmaceuticals Ltd.Wipro Ltd.
Record DateMay 04, 2026Jun 05, 2026
Offer Open DateMay 08, 2026Jun 11, 2026
Offer Closure DateMay 14, 2026Jun 17, 2026
Last date for receipt of tender formsMay 15, 2026Jun 17, 2026
Finalisation of buybackMay 20, 2026Jun 23, 2026
Last Date for settlment of bidsMay 21, 2026Jun 24, 2026
Last Date for extinguishment of sharesJun 02, 2026Jul 06, 2026

Financial Details and Other Relevent Information

Comparison of Jagsonpal Pharmaceuticals Buyback 2026 and Wipro Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Jagsonpal Pharmaceuticals Ltd.Wipro Ltd.
Financial

Company Financials (Restated Consolidated)

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets278.26217.08194.95
Total Income276.91217.98242.45
Profit After Tax55.3622.4626.72
Reserves and Surplus226.67174.18145.79
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Wipro Ltd.'s revenue increased by 5% and profit after tax (PAT) rose by 11% between the financial year ending with March 31, 2026 and March 31, 2025.

Period Ended31 Mar 202631 Mar 202531 Mar 2024
Total Income76,094.2072,522.7069,838.20
Profit After Tax12,129.6010,913.109,118.60
NET Worth63,679.7063,487.4057,781.90
Reserves and Surplus61,582.0061,393.0056,736.90
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2024 513.90 270.05 377.81
Jan-2025 283.55 196.50 225.44
Jan-2026 301.80 154.90 215.07

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Apr-2026 212.75 188.70 202.41
Mar-2026 206.00 186.50 194.28
Feb-2026 260.00 199.20 220.04
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2024 514.85 273.60 377.59
Jan-2025 284.36 196.35 225.37
Jan-2026 301.65 155.00 214.95

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Apr-2026 212.98 188.58 202.41
Mar-2026 205.95 186.50 194.31
Feb-2026 259.89 199.12 220.03

Compare with others

Compare: